Effect of Rivaroxaban vs Enoxaparin on Major Cardiac Adverse Events and Bleeding Risk in the Acute Phase of Acute Coronary Syndrome
Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial
Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease
Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segmentâ€“Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial
Warfarin, Aspirin, or Both after Myocardial Infarction
Heparin versus placebo for non-ST elevation acute coronary syndromes
Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors
Heparin administration at first medical contact vs immediately before primary percutaneous coronary intervention: the HELP-PCI trial
Pretreatment with heparin in patients with ST-segment elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial
